Search
for
Sort by
Research 31–60 of 924
- How to diagnose a lipodystrophy syndrome
- Expression and roles of steroidogenic acute regulatory (StAR) protein in ‘non-classical’, extra-adrenal and extra-gonadal cells and tissues
- γδ17 T cell-stromal networks modulate matrix composition and vascularity in foreign body response
- Urticaria, Drug Hypersensitivity Rashes, Nodules and Tumors, and Atrophic Diseases
- Dunnigan-Type Familial Partial Lipodystrophy: Understanding and Treating the Syndrome
- Potential Role of Cinnamon (<i>Cinnamomum verum</i>) to Reduce the Risk of Polycystic Ovary Syndrome by Managing the Obesity: A Review
- Polycystic Ovary Syndrome: A Comprehensive Review of Pathogenesis, Management, and Drug Repurposing
- Inflammatory perspectives of polycystic ovary syndrome: role of specific mediators and markers
- Obesity in Adults: Position Statement of Polish Association for the Study on Obesity, Polish Association of Endocrinology, Polish Association of Cardiodiabetology, Polish Psychiatric Association, Section of Metabolic and Bariatric Surgery of the Association of Polish Surgeons, and the College of Family Physicians in Poland
- The Biological Actions of Dehydroepiandrosterone Involves Multiple Receptors
- Syndrome des ovaires polykystiques : Point de vue contemporain
- Controversies in plastic surgery: Suction-assisted lipectomy (SAL) and the hCG (human chorionic gonadotropin) protocol for obesity treatment
- Gonadal Sex Steroids: Production, Action and Interactions in Mammals
- Polycystic ovary syndrome: Pathophysiology, Symptoms, Risk factors, and Pharmacological treatment
- Aging and Immortality: Quasi-Programmed Senescence and Its Pharmacologic Inhibition
- Role of Sodium–Glucose Cotransporter-2 Inhibitors in Managing Polycystic Ovary Syndrome: A Systematic Review
- Skin
- Melatonin membrane receptors in peripheral tissues: Distribution and functions
- Clinical-exome sequencing unveils the genetic landscape of polycystic ovarian syndrome (PCOS) focusing on lean and obese phenotypes: implications for cost-effective diagnosis and personalized treatment
- Novel Systematics of Nomenclature and Classification of Female Functional Androgenization (Including Polycystic Ovary Syndrome and Non-Classic Congenital Adrenal Hyperplasia)
- Debatable Topics in PCOS Patients
- Exploring Nanotechnology With Traditional Herbal Pharmacology: Nano Carrier-Based Phytochemical Delivery In PCOS Treatment
- Androgen excess: a hallmark of polycystic ovary syndrome
- Unravelling the link between insulin resistance and androgen excess
- Polycystic Ovarian Syndrome: Exploring Hypertension and Cardiometabolic Implications
- DHEA and TNF-α: Key Factors in Managing Polycystic Ovary Syndrome in Iraqi Females
- Estimation of Dehydroepiandrosterone (DHEA) and Tumor Necrosis Factor–Alpha (TNF-α) Levels Women Diagnosed with Polycystic Syndrome
- Physiologic functions of PP2A: Lessons from genetically modified mice
- Dermatologic manifestations of endocrine disorders
- Genome-wide association study in Japanese females identifies fifteen novel skin-related trait associations